ONCOZ.ST(ONCOZ.ST)
ONCOZ.ST
No analyst ratings available
No analyst price targets available for ONCOZ.ST
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $5M | $14M | $20M |
| Low | $5M | $14M | $20M |
| High | $5M | $14M | $20M |
| EBITDA Avg | $999,999 | $3M | $4M |
| Low | $999,999 | $3M | $4M |
| High | $999,999 | $3M | $4M |
| EBIT Avg | $-999,999 | $-3M | $-4M |
| Low | $-999,999 | $-3M | $-4M |
| High | $-999,999 | $-3M | $-4M |
| Net Income Avg | $-12M | — | — |
| Low | $-12M | — | — |
| High | $-12M | — | — |
| EPS Avg | $-1.00 | — | — |
| Low | $-1.00 | — | — |
| High | $-1.00 | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / — | 1 / — |
| Metric | Q4 2026 |
|---|---|
| Revenue Avg | $3M |
| Low | $3M |
| High | $3M |
| EBITDA Avg | $539,999 |
| Low | $539,999 |
| High | $539,999 |
| EBIT Avg | $-539,999 |
| Low | $-539,999 |
| High | $-539,999 |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |